92548-59-9Relevant academic research and scientific papers
Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A
Im, Eun-Ju,Lee, Chan-Hyeong,Moon, Pyong-Gon,Rangaswamy, Gunassekaran Gowri,Lee, Byungheon,Lee, Jae Man,Lee, Jae-Chul,Jee, Jun-Goo,Bae, Jong-Sup,Kwon, Taeg-Kyu,Kang, Keon-Wook,Jeong, Myeong-Seon,Lee, Joo-Eun,Jung, Hyun-Suk,Ro, Hyun-Joo,Jun, Sangmi,Kang, Wonku,Seo, Seung-Yong,Cho, Young-Eun,Song, Byoung-Joon,Baek, Moon-Chang
, (2019)
Inhibitors of the secretion of cancer exosomes, which promote cancer progression and metastasis, may not only accelerate exosome biology research but also offer therapeutic benefits for cancer patients. Here we identify sulfisoxazole (SFX) as an inhibitor
Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
-
, (2008/06/13)
Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, having reporters comprising gas-filled microbubbles stabilised by monolayers of film-forming surfactants, the reporter being coupled or linked to at least one vector.
